MacuLogix, Inc. is a leading company based in Harrisburg, PA, specializing in the diagnosis and treatment of age-related macular degeneration (AMD). Their innovative technology, including the AdaptDx Pro and Theia, allows eye care professionals to test more patients and detect AMD at an earlier stage, ultimately helping to preserve vision. With a commitment to high-touch patient care and breakthrough dark adaptation testing, MacuLogix is dedicated to preventing unnecessary vision loss and improving the lives of those affected by AMD.
Through their AMD Excellence Program, MacuLogix provides resources, research publications, videos, webinars, and CE e-books to support eye care professionals in their understanding and management of AMD. With a focus on subclinical AMD detection and the importance of impaired dark adaptation as an early biomarker, MacuLogix empowers practices to implement effective strategies for early intervention and patient care. With their cutting-edge technology and dedication to advancing AMD care, MacuLogix is at the forefront of the fight against macular degeneration.
Generated from the website